U.S. Markets close in 2 hrs 23 mins

Sage Therapeutics Inc (SAGE) President & CEO Jeffrey M Jonas Sold $15 million of Shares

- By insider

President & CEO of Sage Therapeutics Inc (SAGE) Jeffrey M Jonas sold 85,736 shares of SAGE on 05/29/2019 at an average price of $174.78 a share. The total sale was $15 million.

Sage Therapeutics Inc is a biopharmaceutical company conducting development programs and clinical trials to discover medicines for central nervous system disorders. It has development programs for refractory status epilepticus, and Parkinson's di-sease. Sage Therapeutics Inc has a market cap of $8.91 billion; its shares were traded at around $174.15 with and P/S ratio of 89.33.


CEO Recent Trades:

  • President & CEO Jeffrey M Jonas sold 85,736 shares of SAGE stock on 05/29/2019 at the average price of $174.78. The price of the stock has decreased by 0.36% since.
  • President & CEO Jeffrey M Jonas sold 94,264 shares of SAGE stock on 05/24/2019 at the average price of $174.75. The price of the stock has decreased by 0.34% since.

Directors and Officers Recent Trades:

  • Chief Business Officer Michael Cloonan sold 25,000 shares of SAGE stock on 05/22/2019 at the average price of $175. The price of the stock has decreased by 0.49% since.
  • SVP, GC & Secretary Anne Marie Cook sold 15,000 shares of SAGE stock on 05/10/2019 at the average price of $166.14. The price of the stock has increased by 4.82% since.
  • Director James M Frates sold 8,000 shares of SAGE stock on 05/06/2019 at the average price of $162.22. The price of the stock has increased by 7.35% since.

For the complete insider trading history of SAGE, click here

.This article first appeared on GuruFocus.